NCT05037331View on ClinicalTrials.gov

Osimertinib for Advanced EGFR-positive NSCLC Patients

RecruitingOBSERVATIONAL

Enrollment

58

Participants

Timeline

Start Date

July 22, 2021

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions

EGFR Positive Non-small Cell Lung CancerNon Small Cell Lung Cancer

Trial Locations (1)

Unknown

RECRUITING

National University Hospital, Singapore

All Listed Sponsors

lead

National University Hospital, Singapore

OTHER